IONIS PHARMACEUTICALS INC (IONS)
US4622221004 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 56.21. This target is 38.17% above the current price.
IONS was analyzed by 30 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-26 | Oppenheimer | Reiterate | Outperform |
| 2024-02-22 | Needham | Reiterate | Buy -> Buy |
| 2024-02-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-01-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-01-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-12-19 | Needham | Reiterate | Buy -> Buy |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-11-17 | Needham | Reiterate | Buy -> Buy |
| 2023-11-03 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-11-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-23 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2023-10-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-29 | Raymond James | Initiate | Strong Buy |
| 2023-09-27 | Needham | Reiterate | Buy -> Buy |
| 2023-09-27 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-07-31 | Citigroup | Upgrade | Neutral -> Buy |
| 2023-05-04 | Needham | Reiterate | Buy |
| 2023-05-04 | RBC Capital | Reiterate | Outperform |
| 2023-05-04 | Barclays | Maintains | Equal-Weight |
| 2023-05-04 | Wells Fargo | Maintains | Overweight |
| 2023-05-04 | Citigroup | Upgrade | Sell -> Neutral |
| 2023-04-25 | Needham | Reiterate | Buy |
| 2023-04-18 | Needham | Reiterate | Buy |